APOH (Beta-2-glycoprotein 1) variants and mutations

APOH (also known as Beta-2-glycoprotein 1) is a human protein-coding gene encoding a beta-2-glycoprotein 1 protein. It binds negatively charged phospholipids and participates in coagulation, lipid metabolism, and clearance of apoptotic material. It is also the major antigen recognized by pathogenic antiphospholipid antibodies in antiphospholipid syndrome. This analysis covers 680 APOH variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes atrial fibrillation, Hypercholesterolemia, and metabolic syndrome. Example APOH variants include M1?, S3Y, and P4L.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable APOH variants

Examples include M1?, S3Y, P4L, P4S, V5A, L6F, L6H, L6V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.